• Boacheng Wang, Josef Briegel, Wolfgang A Krueger, Rika Draenert, Jette Jung, Alexandra Weber, Johannes Bogner, Sören Schubert, Uwe Liebchen, Sandra Frank, Michael Zoller, Michael Irlbeck, Ludwig Ney, Thomas Weig, Ludiwg Hinske, Sebastian Niedermayer, Erich Kilger, Patrick Möhnle, and Beatrice Grabein.
• Department of Anesthesiology, Klinik für Anästhesiologie, Klinikum der Ludwig-Maximilians-Universität (LMU), University Hospital, LMU Munich, Marchioninistrasse 15, 81377, Munich, Germany.
• Intensive Care Med. 2022 Sep 1; 48 (9): 116511751165-1175.

PurposeThis case-control study investigated the long-term evolution of multidrug-resistant bacteria (MDRB) over a 5-year period associated with the use of selective oropharyngeal decontamination (SOD) in the intensive care unit (ICU). In addition, effects on health care-associated infections and ICU mortality were analysed.MethodsWe investigated patients undergoing mechanical ventilation > 48 h in 11 adult ICUs located at 3 campuses of a university hospital. Administrative, clinical, and microbiological data which were routinely recorded electronically served as the basis. We analysed differences in the rates and incidence densities (ID, cases per 1000 patient-days) of MDRB associated with SOD use in all patients and stratified by patient origin (outpatient or inpatient). After propensity score matching, health-care infections and ICU mortality were compared.Results5034 patients were eligible for the study. 1694 patients were not given SOD. There were no differences in the incidence density of MDRB when SOD was used, except for more vancomycin-resistant Enterococcus faecium (0.72/1000 days vs. 0.31/1000 days, p < 0.01), and fewer ESBL-producing Klebsiella pneumoniae (0.22/1000 days vs. 0.56/1000 days, p < 0.01). After propensity score matching, SOD was associated with lower incidence rates of ventilator-associated pneumonia and death in the ICU but not with ICU-acquired bacteremia or urinary tract infection.ConclusionsComparisons of the ICU-acquired MDRB over a 5-year period revealed no differences in incidence density, except for lower rate of ESBL-producing Klebsiella pneumoniae and higher rate of vancomycin-resistant Enterococcus faecium with SOD. Incidence rates of ventilator-associated pneumonia and death in the ICU were lower in patients receiving SOD.© 2022. The Author(s).

19 keywords...

hide…